Crossmark

BRAF V600E Mutation in Papillary Thyroid Cancer and Its Effect on Postoperative Radioiodine ( 131 I) Therapy: Should We Modify Our Therapeutic Strategy?

Crossref DOI link: https://doi.org/10.1016/j.cireng.2018.05.010

Published Print: 2018-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Domínguez Ayala, Maite

Expósito Rodríguez, Amaia

Bilbao González, Amaia

Mínguez Gabiña, Pablo

Gutiérrez Rodríguez, Teresa

Rodeño Ortiz de Zarate, Emilia

García Carrillo, Maitane

Barrios Treviño, Borja
License Information

Text and Data Mining valid from 2018-05-01
More Information

This article is maintained by: Elsevier

Article Title: BRAF V600E Mutation in Papillary Thyroid Cancer and Its Effect on Postoperative Radioiodine (131I) Therapy: Should We Modify Our Therapeutic Strategy?

Journal Title: Cirugía Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cireng.2018.05.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ciresp.2018.02.018

Content Type: article

Copyright: © 2018 AEC. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below